Airuike Cisatracudum Besylate

ATRACURIUMBESILATE;BW-33A;2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinoliniumdibenzenesulfonate;2，2’-[1，5-Pentanediylbis[oxy(3-oxcr3，1-propanediyl)]]bis[1-[(3，4-dimethoxyphenyl)methyl]-1，2，3，4-tetrahChemicalbookydro-6，7-dimethoxy-2-methylisoquinolinium]dibenzenesulfonate;51W-89：Nimbex;AtraeuriumBesylate;CisatracudumBesylate;BW-33A,Tracrium,2,2μ-[1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinolinium]dibenzenesulfonate

Atracurium besylate is a skeletal muscle relaxant for general anesthesia. It is suitable for the treatment of muscle relaxation during endotracheal intubation and muscle relaxation required for thoracoabdominal surgery. Like most neuromuscular blocking agents, it can Causes the release of histamine, skin flushing, transient hypotension, and occasionally bronchospasm. Concomitant use of atracurium besylate with inhaled anesthetic gases such as halogenated alkanes, isoflurane and siflurane may enhance its neuromuscular blocking effect. Simultaneous use with aminoglycosides, polytypic antibiotics, lithium salts, quinidine or procaine Chemicalbookamine may enhance its nerve-blocking effect. This product should not be used in combination with depolarizing muscle relaxants such as chlorosuccinylcholine, as a prolonged complex blocking effect may occur that is difficult to reverse with anticholinese drugs. It is forbidden for those who are allergic to this product. Caution should be exercised when using this product in patients with myasthenia gravis, neuromuscular disease, or severe electrolyte imbalance, as it can potentiate the effects of other non-depolarizing agents. People with severe cardiovascular disease are more sensitive to the temporary hypotensive reaction of this product, so it is recommended to give it a slow intravenous injection in batches.